Funding profile · Virtual pulmonary rehabilitation

Kivo Health

Kivo Health’s own Y Combinator page says it raised a $10 million Series A. No SEC Form D for the company exists to confirm it, and a third party aggregator puts total funding at $500,000. Here is what the record actually shows.

$10.0MSeries A, company-reported on Y Combinator page
$500KTotal funding reported by Tracxn, from a 2023 seed round
0Form D notices found under Kivo Health on SEC EDGAR
2024Year MassMutual Ventures dates its initial investment

Data as of September 25, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
2023 Y Combinator, Winter 2023 Not disclosed Y Combinator YC data
2023 Seed, aggregate $500,000 reported Y Combinator and, per Tracxn, MassMutual Ventures and 3 other investors Third party data
2024 Additional investment Not disclosed MassMutual Ventures Investor-stated
By early 2023 Series A $10,000,000 stated Not named Company-stated

What the filings show

There is nothing to show. A search of SEC EDGAR’s full text index for the exact phrase “Kivo Health,” with and without a Form D filter, returns zero filings. A separate search of EDGAR’s company database for any issuer named “Kivo” that has filed a Form D turns up only one match, and it is a different business: Kivo, Inc. of Portland, Oregon, formerly named Virtual Regulatory Solutions, Inc., run by Toban Zolman, which sells regulatory submission software to life sciences companies and has filed five Form D notices under CIK 0001917508 between 2022 and 2025. None of those filings name Kivo Health, its founders, or its investors.

That leaves the company’s own Y Combinator page, which states in the founders’ section that Kivo Health “just raised our $10M Series A,” as the only source for that figure. No press release, investor announcement, or filing naming a lead investor, valuation, or close date for that round was found anywhere in this research.

Reading the filings

  1. No Form D exists for Kivo Health.A $10 million Series A of the kind described on the company’s Y Combinator page would ordinarily require a Form D within 15 days of the first sale of securities under Regulation D, unless the raise was structured entirely as convertible notes or SAFEs below the reporting threshold, or under an exemption that does not require the filing. As of September 25, 2026, none has appeared.
  2. The name looks like it should collide with a real filer, and does not.Kivo, Inc. of Portland, Oregon is a going concern with its own Form D history, its own CEO, and no connection to Kivo Health beyond a shared short name. Anyone searching SEC EDGAR for “Kivo” will find that company first.
  3. Third party estimates and the company do not agree.Tracxn, a data aggregator, lists Kivo Health’s total funding as $500,000 from a single 2023 seed round tied to Y Combinator. That is 5 percent of the $10 million the company’s own page claims for its Series A alone.
  4. An investor’s own timeline sits awkwardly against the company’s claim.MassMutual Ventures lists 2024 as the year of its initial funding in Kivo Health, a year after the Y Combinator page’s Series A language first appeared. Whether that investment was part of the stated Series A, a later round, or a separate check cannot be determined from public sources.
  5. Absence of a filing is evidence of absence here, not proof of nothing happening.Kivo Health plainly has institutional backing: it operates partnerships with Stanford Health Care, Optum Arcadia and Priority Health, and it lists a Y Combinator batch, a UCSF Rosenman Institute affiliation, and an investor with its own public portfolio page. What is missing is any document that states, with a name attached, how much money changed hands.

Commercial signals

Signal Detail Source type
Clinical evidence Peer reviewed retrospective study of 167 patients, published Feb 2025 in Chronic Obstr Pulm Dis. 88 percent median attendance, about 1 percent adverse event rate. Public record
Health system partnership Stanford Health Care collaboration announced Jun 2025 for value based COPD care. Company-stated
Payer partnership Priority Health, covering more than 1.3 million Michigan members, partnered Dec 2025 for Medicare, Medicaid and HIDE-SNP members. Company-stated
Managed care partnership Optum Arcadia and Optum California launched a joint program Apr 2026 combining clinician led care coordination with Kivo’s platform. Company-stated
Team size Y Combinator lists a current team size of 40. A separate, unverified secondary aggregator profile cites 14 people in 2024 and about 31 more recently. Differs across sources
Regulatory status No FDA 510(k) or PMA filing found. No NIH or NSF award found under Kivo Health. Not found

What to watch

  • A Form D or other public filing that names investors and confirms the size of the reported Series A.
  • Whether MassMutual Ventures or any other investor is named as a lead on that round.
  • Independent, named reporting of the company’s revenue, patient volume or team size, none of which was found in this research.
  • Whether the company clarifies, on its own materials, that it is unrelated to Kivo, Inc. of Portland, Oregon.

The Kivo Health story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Synapticure: Also in Healthcare Services. A virtual specialty clinic for ALS, Parkinson’s and dementia, built by an ALS patient and his caregiver
  • Call9: Also in Healthcare Services. A company that put emergency medicine inside nursing homes, with first responders at the bedside and emergency physicians on a screen
  • Alfie: Also in Healthcare Services. A New York telehealth clinic that used an AI model called ObesityRx to match patients with weight loss medications and behavior changes
  • Pair Team: Also in Healthcare Services. A California medical group delivering Medicaid Enhanced Care Management to people living in shelters, cars and encampments

Sources

  1. Public recordSEC EDGAR full text search, “Kivo Health” (zero Form D results)SEC EDGAR · accessed Sep 25, 2026
  2. Public recordForm D filings, Kivo, Inc., CIK 0001917508SEC EDGAR · 2022 to 2025
  3. Public recordFilizola H, Kumar A, Buhr RG, Schwab Jensen K. Outcomes of virtual pulmonary rehabilitation in oxygen-dependent COPD patientsChronic Obstr Pulm Dis, PMID 40037281 · Feb 28, 2025
  4. InvestorMassMutual Ventures portfolio page, Kivo HealthMassMutual Ventures · archived May 2, 2025
  5. Third party dataKivo Health funding rounds and investorsTracxn · accessed Sep 25, 2026
  6. CompanyKivo Health: AI-powered care for seniors with chronic diseaseY Combinator company page · accessed Sep 25, 2026
  7. CompanyOptum Arcadia and Kivo Health launch AI-powered, virtual lung rehab and care for patients in CaliforniaBusiness Wire · Apr 13, 2026
  8. CompanyStanford Health Care and Kivo Health collaborate to advance value based care for COPD through virtual pulmonary rehabilitationBusiness Wire · Jun 11, 2025
  9. IndependentPriority Health partners with Kivo Health to deliver AI-powered virtual COPD carePriority Health · Dec 10, 2025

Compiled from SEC and other public records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in Kivo Health. This page is not an offer to sell or a recommendation to buy any security.